Study of ALTO-300 in MDD

NCT05922878 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ALTO-300
DRUG: Placebo

Sponsor

Alto Neuroscience